Navigation Links
Aranesp Phase 3 Study in Patients with Active Cancer Not Receiving,Concurrent Chemotherapy or Radiotherapy Presented at AACR Annual,Meeting

ts with metastatic breast cancer receiving chemotherapy when administered to target a hemoglobin of greater than 12 g/dL;

-- increased the risk of death when administered to target a hemoglobin of 12 g/dL in patients with active malignant disease receiving neither chemotherapy nor radiation therapy. ESAs are not indicated for this population.

(See WARNINGS: Increased Mortality and/or Tumor Progression in the prescribing information).

The Aranesp prescribing information, including important safety information and boxed warning, may be accessed at www.aranesp.com.

About Amgen

Amgen discovers, develops and delivers innovative human therapeutics. A biotechnology pioneer since 1980, Amgen was one of the first companies to realize the new science's promise by bringing safe and effective medicines from lab, to manufacturing plant, to patient. Amgen therapeutics have changed the practice of medicine, helping millions of people around the world in the fight against cancer, kidney disease, rheumatoid arthritis, and other serious illnesses. With a deep and broad pipeline of potential new medicines, Amgen remains committed to advancing science to dramatically improve people's lives. To learn more about our pioneering science and our vital medicines, visit www.amgen.com.

Forward-Looking Statement This news release contains forward-looking statements that involve significant risks and uncertainties, including those discussed below and others that can be found in Amgen's Form 10-K for the year ended December 31, 2006, and in Amgen's periodic reports on Form 10-Q and Form 8-K. Amgen is providing this information as of the date of this news release and does not undertake any obligation to update any forward-looking statements contained in this document as a result of new information, future events or otherwise.

No forward-looking statement can be guaranteed and actual results may differ materially from those Amgen projects. Discovery
'"/>




Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Aranesp ``145 Study Shows No Difference in Survival in Patients with Small-Cell Lung Cancer
2. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
3. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
4. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
5. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
6. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
7. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
8. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
9. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product
10. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
11. Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery
Post Your Comments:
(Date:12/15/2014)... Research and Markets ( http://www.researchandmarkets.com/research/bf3b6l/electrocardiogram ) ... Devices - Global Trends, Estimates and Forecasts, 2012-2018" ... http://photos.prnewswire.com/prnh/20130307/600769 Global Electrocardiogram Devices (ECG) sector ... North America accounts for nearly ... Europe claims approximately 27% (2018). ...
(Date:12/15/2014)... 12, 2014 Research and Markets ... http://www.researchandmarkets.com/research/ms3j8c/cardiac ) has announced the addition of the ...  report to their offering. Global Guidewires sector is ... North America accounts for nearly 35% ... claims approximately 25% (2018). Asia-Pacific ...
(Date:12/15/2014)... Israel , Dec. 15, 2014  Immune Pharmaceuticals Inc. ... that its Board of Directors has elected Mr. Daniel Kazado ... who continues as Chief Executive Officer of Immune. Mr. Kazado ... 2013. Immune,s new Chairman, Mr. Daniel Kazado ... shareholders and to continue to support the strategic vision of ...
Breaking Medicine Technology:Electrocardiogram (ECG) Devices - Global Trends, Estimates and Forecasts, 2012-2018 2Electrocardiogram (ECG) Devices - Global Trends, Estimates and Forecasts, 2012-2018 3Electrocardiogram (ECG) Devices - Global Trends, Estimates and Forecasts, 2012-2018 4Cardiac Guidewires - Global Trends, Estimates and Forecasts, 2012-2018 2Cardiac Guidewires - Global Trends, Estimates and Forecasts, 2012-2018 3Cardiac Guidewires - Global Trends, Estimates and Forecasts, 2012-2018 4Immune Pharmaceuticals Elects Daniel Kazado as New Chairman of the Board. 2Immune Pharmaceuticals Elects Daniel Kazado as New Chairman of the Board. 3Immune Pharmaceuticals Elects Daniel Kazado as New Chairman of the Board. 4
... Pa., Aug. 9, 2011 Styron, the global ... rubber, announced an addition to its EMERGE™ Advanced ... PC/PET 9100CR Advanced Resin is a polycarbonate ... for medical equipment housing applications. (Logo: ...
... Inc. (Nasdaq: CYBX ) today announced that the company ... 2011 of its fiscal year ending April 27, 2012, on Thursday, ... conduct a conference call to discuss those results on the same ... Fiscal Year 2012 First Quarter Results Conference Call Instructions ...
Cached Medicine Technology:Styron Introduces Chemical Resistance Blends for Medical Housings 2Cyberonics to Report Fiscal Year 2012 First Quarter Results and Host Conference Call on August 25, 2011 2
(Date:12/15/2014)... 15, 2014 Main Street Dental Team ... weighing in on a new study providing evidence on ... oral hygiene of children. , Sufficient enough evidence already ... as pop or juice drinks, with the onset of ... is whether drinks listed as 100% fruit juice, meaning ...
(Date:12/15/2014)... a leading mobile app development company , custom ... which allows users to keep track of wines they ... right wine. At the center of WineMatch is ... wine information. All this information is assembled to help ... are close counterparts to one another are called Matches. ...
(Date:12/15/2014)... Health Dialog, a leading provider of ... has received Patient Oriented Accreditation from the National ... Management (DM) Programs for asthma, congestive heart failure, ... and diabetes. This marks the 12th continuous year ... Management (DM) Programs, reaffirming Health Dialog’s focus and ...
(Date:12/15/2014)... pilots process visual information more efficiently than less experienced ... landings, a new study shows. Landing is one ... and 36 percent of all airplane crashes and 25 ... landing. Researchers monitored the brain activity of eight ... were at the controls of a flight simulator. As ...
(Date:12/15/2014)... December 15, 2014 Kathy McAfee, America's ... Women World Awards in the category of Best Blog ... award for her weekly career blog Networking Ahead ... to help professionals elevate their talent and influence through ... named after her book Networking Ahead for Business, has ...
Breaking Medicine News(10 mins):Health News:Main Street Dental Team, Unionville’s Most Innovative Dental Clinic, Comments on New Study Relating Pure Fruit Juice to Poor Oral Hygiene 2Health News:Use WinMatch Connect App to Keep Track of Wines You Like 2Health News:Health Dialog Receives NCQA Accreditation for Disease Management Programs 2Health News:Study Shows Why Expert Pilots Are Experts 2Health News:Kathy McAfee, America’s Marketing Motivator, Wins Best Blog from Women World Awards 2
... from one another? UCLA biologists working as "evolutionary ... and South America, and they offer some answers in research published ... Proceedings of the Royal Society B. The faces they ... "If you look at New World primates, you,re immediately ...
... condescendingly, excluded from a meeting, or ignored by a supervisor. ... depending on whether your co-worker is a man or a ... towards colleagues feel negative emotions especially when the incivility ... by Kathi Miner from Texas A&M University and Angela Eischeid ...
... Florida and 14 additional medical centers reported results today in ... indicating that deep brain stimulation also known as DBS ... life in patients with advanced Parkinson,s disease. The study, ... effectiveness of a constant current DBS device developed by St. ...
... more dietary fiber to improve our health - that,s the ... team has looked at research conducted into dietary fiber during ... that to avoid initial problems, such as intestinal gas and ... to spread high-fiber foods out throughout the day, at meals ...
... Reinberg HealthDay Reporter , TUESDAY, Jan. 10 (HealthDay ... exenatide (Byetta, Bydureon) might also be used to help the ... loss and lowered cholesterol are often side effects of ... team noted. "If you use this treatment for 20 ...
... Having a brother or sister with newly diagnosed cancer can ... most children eventually cope, there can be a period of ... research published in BioMed Central,s open access journal Child ... teaching program, designed to improve the child,s knowledge about their ...
Cached Medicine News:Health News:Evolution is written all over your face 2Health News:Evolution is written all over your face 3Health News:Evolution is written all over your face 4Health News:'I feel your pain ...' 2Health News:Parkinson's treatment shows positive results in clinical testing 2Health News:Parkinson's treatment shows positive results in clinical testing 3Health News:Increase dietary fiber, decrease disease 2Health News:Certain Diabetes Drugs Might Aid Weight Loss 2Health News:Certain Diabetes Drugs Might Aid Weight Loss 3Health News:Certain Diabetes Drugs Might Aid Weight Loss 4Health News:New educational program helps the siblings of children with cancer 2
... The MicroDigital IP 6.2 Series Image ... 3-chip camera for all surgical specialties. This ... camera functions such as brightness, enhancement, gain, ... your fingertips. Multiple-range image enhancement and adjustable ...
... ALU-2B Halogen Light Source is ... the addition of dual lamps ... This light source is ideal ... has the added feature of ...
Combination Ultrasonic and Pneumatic Urological Lithotriptor. Consists of four sizes of rigid pneumatic probes for use in the kidney, ureter and bladder....
All the power and performance of the STS - T but now available with a stand-alone 9" II C-Arm...
Medicine Products: